— Know what they know.
Not Investment Advice

SBRA NASDAQ

Sabra Health Care REIT, Inc.
1W: -0.9% 1M: +5.8% 3M: +3.9% YTD: +9.8% 1Y: +18.4% 3Y: +127.1% 5Y: +75.1%
$20.72
+0.01 (+0.05%)
 
Weekly Expected Move ±2.6%
$20 $20 $21 $21 $22
NASDAQ · Real Estate · REIT - Healthcare Facilities · Alpha Radar Buy · Power 60 · $5.2B mcap · 247M float · 0.922% daily turnover · Short 49% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 4.4%  ·  5Y Avg: 0.8%
Cost Advantage
45
Intangibles
33
Switching Cost
33
Network Effect
28
Scale ★
52
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SBRA has No discernible competitive edge (37.5/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 4.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$22
Low
$22
Avg Target
$22
High
Based on 3 analysts since Apr 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 16Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$22.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-21 Scotiabank $15 $22 +7 +5.7% $20.81
2026-05-13 UBS Michael Goldsmith $21 $22 +1 +4.9% $20.97
2026-05-11 Cantor Fitzgerald Richard Anderson $21 $22 +1 +6.0% $20.75
2026-02-19 UBS Michael Goldsmith Initiated $21 +3.8% $20.23
2026-02-17 Cantor Fitzgerald Richard Anderson $20 $21 +1 +4.1% $20.17
2026-01-20 Truist Financial Michael Lewis $20 $21 +1 +9.1% $19.24
2025-12-15 Jefferies Joe Dickstein $19 $22 +3 +14.6% $19.20
2025-11-25 Wells Fargo $20 $21 +1 +10.9% $18.94
2025-10-21 Wells Fargo Initiated $20 +8.5% $18.43
2025-10-17 National Bank Initiated $22 +22.0% $18.04
2025-10-01 Cantor Fitzgerald Richard Anderson Initiated $20 +7.3% $18.64
2025-09-02 Truist Financial $18 $20 +2 +3.8% $19.26
2024-09-12 Citigroup Nicholas Joseph Initiated $20 +9.0% $18.35
2024-09-03 Truist Financial Michael Lewis $16 $18 +2 +5.9% $17.00
2024-06-21 Robert W. Baird David Rodgers Initiated $16 +10.0% $14.55
2024-05-15 Scotiabank Nicholas Yulico Initiated $15 +2.2% $14.67
2023-05-31 Credit Suisse Omotayo Okusanya Initiated $13 +21.7% $10.68
2021-12-26 Truist Financial Michael R Lewis Initiated $16 +22.1% $13.10
2021-08-23 Jefferies Jonathan Petersen Initiated $19 +23.8% $15.35
2021-05-03 Capital One Financial Daniel Bernstein Initiated $20 +21.7% $16.43

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
5
ROE
3
ROA
4
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SBRA receives an overall rating of B. Strongest factors: DCF (5/5), ROA (4/5). Areas of concern: D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-11 B+ B
2026-04-01 B B+
2026-03-02 B+ B
2026-01-20 B B+
2026-01-16 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

53 Grade A
Profitability
51
Balance Sheet
35
Earnings Quality
79
Growth
56
Value
50
Momentum
84
Safety
15
Cash Flow
79
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SBRA scores highest in Momentum (84/100) and lowest in Safety (15/100). An overall grade of A places SBRA among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.65
Distress Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.68
Unlikely Manipulator
Ohlson O-Score
-7.06
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
B+
Score: 33.2/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 2.35x
Accruals: -3.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SBRA scores 0.65, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SBRA scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SBRA's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SBRA's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SBRA receives an estimated rating of B+ (score: 33.2/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SBRA's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
33.45x
PEG
5.02x
P/S
6.43x
P/B
1.88x
P/FCF
13.42x
P/OCF
13.42x
EV/EBITDA
16.89x
EV/Revenue
9.11x
EV/EBIT
30.65x
EV/FCF
20.18x
Earnings Yield
3.17%
FCF Yield
7.45%
Shareholder Yield
6.14%
Graham Number
$12.30
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 33.4x earnings, SBRA commands a growth premium. Graham's intrinsic value formula yields $12.30 per share, 68% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
0.646
EBT / EBIT
×
EBIT Margin
0.297
EBIT / Rev
×
Asset Turnover
0.151
Rev / Assets
×
Equity Multiplier
1.941
Assets / Equity
=
ROE
5.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SBRA's ROE of 5.6% is driven by a balanced combination of operating margin, asset efficiency, and leverage. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
4.16%
Fair P/E
16.83x
Intrinsic Value
$10.27
Price/Value
1.87x
Margin of Safety
-87.27%
Premium
87.27%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SBRA's realized 4.2% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. SBRA trades at a 87% premium to its adjusted intrinsic value of $10.27, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 16.8x compares to the current market P/E of 33.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$20.72
Median 1Y
$20.85
5th Pctile
$10.62
95th Pctile
$40.95
Ann. Volatility
40.4%
Analyst Target
$22.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard K. Matros
Chief Executive Officer, President & Chair of the Board
$1,000,000 $5,026,721 $8,552,721
Michael L. Costa
Chief Financial Officer, Executive Vice President & Treasurer
$645,000 $2,010,696 $3,755,876
Talya Nevo-Hacohen Investment
ef Investment Officer, Treasurer & Executive Vice President
$715,000 $— $1,933,060

CEO Pay Ratio

9:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $8,552,721
Avg Employee Cost (SGA/emp): $926,034
Employees: 58

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
58
+16.0% YoY
Revenue / Employee
$13,355,724
Rev: $774,632,000
Profit / Employee
$2,682,914
NI: $155,609,000
SGA / Employee
$926,034
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -0.7% -1.5% -3.3% -3.1% 1.3% -0.5% -2.4% -4.0% -3.8% -2.7% 0.5% 1.7% 1.8% 3.3% 4.6% 5.1% 6.6% 6.3% 5.6% 5.6% 5.62%
ROA -0.4% -0.9% -1.9% -1.8% 0.7% -0.3% -1.3% -2.2% -2.1% -1.5% 0.2% 0.9% 0.9% 1.7% 2.4% 2.6% 3.4% 3.3% 2.9% 2.9% 2.89%
ROIC 3.8% 5.7% 2.9% 3.0% 6.6% 3.1% 4.7% 4.6% 4.5% 3.3% 4.3% 4.0% 3.3% 4.6% 5.0% 5.2% 5.3% 5.1% 4.9% 4.4% 4.39%
ROCE 1.7% 3.9% 0.6% 0.7% 3.5% 0.7% 2.6% 2.4% 2.3% 1.9% 3.2% 3.3% 3.3% 4.1% 4.9% 5.2% 6.0% 5.8% 6.4% 5.7% 5.70%
Gross Margin 3.0% 87.6% 2.2% 75.6% 74.8% 69.5% 47.8% 70.3% 69.4% 69.8% 69.5% 67.6% 68.9% 67.1% 67.2% 67.3% 67.7% 63.3% 62.0% 61.4% 61.38%
Operating Margin 3.5% 84.6% 2.4% 69.0% 69.2% 62.4% 34.9% 63.8% 63.4% 0.0% 33.2% 34.8% 38.0% 36.2% 36.9% 36.7% 38.0% 31.3% 30.5% 17.8% 17.80%
Net Margin 7.9% 3.5% 78.7% 25.7% 11.0% -36.7% -1.0% -5.9% 13.2% -9.3% 10.5% 15.7% 13.6% 16.7% 25.6% 22.0% 34.7% 11.9% 12.8% 18.4% 18.43%
EBITDA Margin 3.5% 84.6% 2.0% 69.0% 69.2% 62.4% 27.0% 63.8% 63.4% 35.1% 54.1% 58.8% 54.2% 57.1% 68.7% 60.6% 72.5% 52.8% 51.0% 41.8% 41.76%
FCF Margin 70.9% 55.3% 91.8% 88.0% 60.4% 83.0% 59.4% 60.0% 58.1% 36.8% 34.0% 31.3% 32.1% 45.2% 44.2% 46.9% 46.2% 45.8% 45.0% 45.1% 45.11%
OCF Margin 76.3% 59.3% 91.8% 88.0% 60.4% 83.0% 59.4% 60.0% 58.1% 51.1% 46.5% 43.7% 44.1% 45.2% 44.2% 46.9% 46.2% 45.8% 45.0% 45.1% 45.11%
ROE 3Y Avg snapshot only 4.15%
ROE 5Y Avg snapshot only 1.02%
ROA 3Y Avg snapshot only 2.14%
ROIC 3Y Avg snapshot only 2.68%
ROIC Economic snapshot only 4.34%
Cash ROA snapshot only 6.68%
Cash ROIC snapshot only 6.92%
CROIC snapshot only 6.92%
NOPAT Margin snapshot only 28.62%
Pretax Margin snapshot only 19.20%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 6.87%
SBC / Revenue snapshot only 1.45%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -106.57 -44.42 -19.55 -23.90 56.32 -136.61 -29.08 -16.75 -18.31 -30.88 209.03 61.53 62.10 41.71 30.60 28.37 23.59 25.51 30.77 31.52 33.449
P/S Ratio 6.13 3.92 5.70 6.36 4.28 5.57 4.24 4.00 4.17 4.81 4.45 4.67 4.86 5.92 5.51 5.55 5.87 6.00 6.18 6.06 6.429
P/B Ratio 0.80 0.67 0.66 0.75 0.72 0.69 0.74 0.70 0.74 0.89 1.03 1.09 1.16 1.45 1.41 1.46 1.57 1.63 1.70 1.74 1.875
P/FCF 8.65 7.09 6.21 7.22 7.09 6.71 7.15 6.66 7.17 13.07 13.07 14.90 15.15 13.10 12.49 11.82 12.69 13.09 13.73 13.42 13.423
P/OCF 8.04 6.61 6.21 7.22 7.09 6.71 7.15 6.66 7.17 9.43 9.57 10.68 11.01 13.10 12.49 11.82 12.69 13.09 13.73 13.42 13.423
EV/EBITDA 18.49 11.32 20.16 20.97 11.99 19.51 14.73 14.66 15.25 18.43 15.11 15.80 16.69 16.84 14.90 14.71 14.06 14.45 15.91 16.89 16.892
EV/Revenue 11.46 7.95 11.71 12.20 8.38 11.17 8.94 8.68 8.78 9.22 8.17 8.36 8.46 9.44 8.90 8.86 9.12 9.19 9.38 9.11 9.105
EV/EBIT 51.49 19.85 138.01 125.58 23.41 110.20 33.53 36.34 38.27 52.20 31.75 31.71 33.66 30.26 24.97 24.21 22.04 23.13 26.93 30.65 30.646
EV/FCF 16.15 14.39 12.76 13.87 13.87 13.45 15.06 14.45 15.12 25.04 24.01 26.66 26.38 20.88 20.16 18.87 19.73 20.08 20.84 20.18 20.182
Earnings Yield -0.9% -2.3% -5.1% -4.2% 1.8% -0.7% -3.4% -6.0% -5.5% -3.2% 0.5% 1.6% 1.6% 2.4% 3.3% 3.5% 4.2% 3.9% 3.3% 3.2% 3.17%
FCF Yield 11.6% 14.1% 16.1% 13.8% 14.1% 14.9% 14.0% 15.0% 13.9% 7.7% 7.6% 6.7% 6.6% 7.6% 8.0% 8.5% 7.9% 7.6% 7.3% 7.5% 7.45%
PEG Ratio snapshot only 5.017
Price/Tangible Book snapshot only 1.786
EV/OCF snapshot only 20.182
EV/Gross Profit snapshot only 14.342
Acquirers Multiple snapshot only 31.418
Shareholder Yield snapshot only 6.14%
Graham Number snapshot only $12.30
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.78 1.78 1.78 1.78 0.59 0.59 0.59 0.59 0.78 0.78 0.78 0.78 0.88 0.88 0.88 0.88 0.15 0.15 0.145
Quick Ratio 1.78 1.78 1.78 1.78 0.59 0.59 0.59 0.59 0.78 0.78 0.78 0.78 0.88 0.88 0.88 0.88 0.15 0.15 0.145
Debt/Equity 0.71 0.71 0.72 0.72 0.72 0.72 0.83 0.83 0.83 0.83 0.87 0.87 0.87 0.87 0.89 0.89 0.89 0.89 0.90 0.90 0.904
Net Debt/Equity 0.69 0.69 0.69 0.69 0.69 0.69 0.82 0.82 0.82 0.82 0.86 0.86 0.86 0.86 0.87 0.87 0.87 0.87 0.88 0.88 0.878
Debt/Assets 0.41 0.41 0.41 0.41 0.41 0.41 0.44 0.44 0.44 0.44 0.45 0.45 0.45 0.45 0.46 0.46 0.46 0.46 0.46 0.46 0.464
Debt/EBITDA 8.83 5.89 10.84 10.53 6.14 10.24 7.89 8.06 8.17 8.99 7.00 7.09 7.22 6.38 5.82 5.64 5.14 5.16 5.58 5.82 5.821
Net Debt/EBITDA 8.59 5.74 10.34 10.05 5.86 9.77 7.74 7.90 8.01 8.81 6.88 6.97 7.10 6.27 5.67 5.50 5.01 5.03 5.43 5.66 5.657
Interest Coverage 1.01 2.41 0.33 0.39 2.03 0.41 1.34 1.17 1.11 0.89 1.29 1.34 1.30 1.63 2.18 2.31 2.70 2.60 2.35 2.08 2.083
Equity Multiplier 1.76 1.76 1.77 1.77 1.77 1.77 1.88 1.88 1.88 1.88 1.92 1.92 1.92 1.92 1.93 1.93 1.93 1.93 1.95 1.95 1.947
Cash Ratio snapshot only 0.057
Debt Service Coverage snapshot only 3.779
Cash to Debt snapshot only 0.028
FCF to Debt snapshot only 0.144
Defensive Interval snapshot only 237.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.07 0.10 0.06 0.07 0.10 0.07 0.09 0.09 0.09 0.10 0.12 0.12 0.12 0.12 0.13 0.13 0.14 0.14 0.14 0.15 0.151
Inventory Turnover
Receivables Turnover 5.62 5.78 8.24 6.04 3.72 3.74 3.79 3.96 4.59 4.63 4.74 4.86 5.30 5.42 5.52 5.61 6.37 6.69 6.689
Payables Turnover
DSO 0 0 65 63 44 60 98 98 96 92 80 79 77 75 69 67 66 65 57 55 54.6 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash Conversion Cycle 0 0 65 63 44 60 98 98 96 92 80 79 77 75 69 67 66 65 57 55
Cash Velocity snapshot only 11.363
Capital Intensity snapshot only 6.758
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -17.8% 9.4% -35.4% -33.6% 28.2% -28.9% 37.0% 34.0% -4.9% 36.0% 21.4% 22.1% 23.3% 20.7% 8.9% 10.4% 9.8% 8.9% 10.2% 12.9% 12.89%
Net Income -1.2% -1.4% -1.8% -1.8% 2.7% 67.2% 31.5% -20.4% -3.8% -4.2% 1.2% 1.4% 1.4% 2.1% 8.2% 1.8% 2.5% 80.2% 22.8% 11.0% 10.96%
EPS -1.2% -1.3% -1.8% -1.7% 2.6% 68.4% 32.5% -20.6% -3.8% -4.2% 1.2% 1.4% 1.4% 2.1% 8.0% 1.8% 2.4% 75.4% 16.4% 4.2% 4.16%
FCF -9.8% -10.2% 7.6% 8.0% 9.2% 6.7% -11.4% -8.6% -8.5% -39.7% -30.3% -36.3% -31.9% 48.1% 41.2% 65.3% 58.2% 10.3% 12.3% 8.5% 8.49%
EBITDA -28.0% 8.9% -48.5% -46.5% 44.5% -42.1% 43.3% 36.3% -21.6% 18.8% 8.2% 9.1% 8.5% 35.2% 20.3% 25.7% 40.4% 23.6% 8.7% 1.0% 1.04%
Op. Income -18.9% 9.0% -51.7% -49.7% 39.2% -45.5% 55.5% 47.7% -17.1% 3.7% -21.6% -33.7% -43.7% 4.3% -0.8% 24.3% 51.2% 9.3% 2.7% -11.4% -11.45%
OCF Growth snapshot only 8.49%
Asset Growth snapshot only 3.58%
Equity Growth snapshot only 2.94%
Debt Growth snapshot only 4.33%
Shares Change snapshot only 6.52%
Dividend Growth snapshot only 4.15%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -10.1% -3.4% -14.6% -12.4% -4.2% -13.5% -4.4% -4.8% 0.1% 1.9% 2.4% 2.8% 14.6% 5.3% 21.9% 21.8% 8.8% 21.4% 13.3% 15.0% 15.00%
Revenue 5Y 11.0% 17.2% 8.3% 8.9% 17.8% 6.7% 5.6% 1.0% -2.4% -2.7% 0.7% 1.9% 0.6% 1.2% 2.9% 3.1% 6.3% 6.8% 5.2% 6.2% 6.23%
EPS 3Y 16.0% -55.3% -30.9% 59.4%
EPS 5Y -30.9% -47.7% -22.1% 13.3% 51.5% 8.8% -7.9% 4.1% 1.1% -1.4% -1.0% -1.03%
Net Income 3Y 25.7% -53.7% -28.7% 61.5%
Net Income 5Y -11.0% -44.8% -17.8% 19.1% 58.0% 12.9% -5.0% 7.4% 4.4% 2.4% 2.7% 2.71%
EBITDA 3Y -24.4% -14.9% -28.2% -18.8% 3.3% -11.6% 0.0% -11.7% -6.6% -9.2% -7.3% -7.4% 7.2% -2.4% 23.1% 23.2% 6.1% 25.7% 12.2% 11.5% 11.46%
EBITDA 5Y 6.8% 13.4% 1.0% 1.6% 13.5% 0.5% -0.3% -6.9% -13.3% -15.8% -10.5% -4.5% -1.2% 2.1% 5.4% -1.2% 4.4% 4.6% 0.8% 0.2% 0.18%
Gross Profit 3Y -18.7% -9.7% -24.5% -22.1% -9.9% -22.1% -9.6% -9.9% -4.7% -2.7% -1.5% -1.3% 14.2% 1.4% 24.5% 24.1% 5.5% 23.6% 10.9% 12.5% 12.47%
Gross Profit 5Y 3.9% 11.5% -0.7% 0.1% 11.7% -1.8% -1.0% -5.5% -9.0% -9.1% -4.7% -3.5% -4.3% -3.4% -1.0% -0.4% 3.5% 3.9% 1.3% 2.0% 1.97%
Op. Income 3Y -7.5% 4.7% -11.6% -7.4% 7.7% -9.4% -0.1% -4.6% -2.2% -14.9% -16.2% -21.1% -13.4% -16.1% 6.6% 6.8% -11.0% 5.7% -7.2% -10.0% -9.99%
Op. Income 5Y 11.3% 20.7% 5.7% 6.8% 22.9% 6.7% 8.7% 2.8% -1.8% -8.3% -3.4% -4.9% -10.2% -4.2% -5.0% -6.5% -4.4% -6.8% -9.7% -11.5% -11.55%
FCF 3Y 10.5% 12.2% -2.7% -5.6% -6.5% -5.4% -6.6% -3.4% -16.7% -12.8% -14.3% -12.0% -1.6% -4.5% -1.2% -0.5% -0.5% 3.4% 4.5% 4.55%
FCF 5Y 13.9% 13.0% 15.1% 13.9% 20.4% -2.8% -2.7% -11.7% -12.1% -6.1% -3.6% -3.0% -0.6% -1.1% 1.0% 2.4% 2.45%
OCF 3Y 5.2% -1.7% -0.2% 4.1% 0.5% -0.6% -5.4% -6.6% -3.4% -7.1% -5.4% -6.5% -4.5% -3.8% -4.5% -1.2% -0.5% -0.5% 3.4% 4.5% 4.55%
OCF 5Y 15.6% 14.6% 15.1% 13.9% 20.4% 30.1% 18.8% 9.5% 1.6% -4.6% -3.5% -1.7% -2.7% -2.6% -3.6% -3.0% -0.6% -1.1% -0.4% 1.0% 1.02%
Assets 3Y -5.2% -5.2% -3.6% -3.6% -3.6% -3.6% -1.8% -1.8% -1.8% -1.8% -3.5% -3.5% -3.5% -3.5% -3.9% -3.9% -3.9% -3.9% -1.5% -1.5% -1.50%
Assets 5Y 19.2% 19.2% 21.4% 21.4% 21.4% 21.4% -4.0% -4.0% -4.0% -4.0% -4.2% -4.2% -4.2% -4.2% -2.7% -2.7% -2.7% -2.7% -1.7% -1.7% -1.70%
Equity 3Y -0.2% -0.2% 1.3% 1.3% 1.3% 1.3% -4.3% -4.3% -4.3% -4.3% -6.3% -6.3% -6.3% -6.3% -6.7% -6.7% -6.7% -6.7% -2.6% -2.6% -2.63%
Book Value 3Y -6.4% -7.2% -6.6% -7.1% -6.5% -4.8% -8.9% -7.9% -8.0% -7.8% -9.6% -9.2% -8.7% -8.3% -8.3% -7.9% -7.9% -8.4% -5.5% -5.9% -5.88%
Dividend 3Y -14.0% -12.0% -9.5% -6.0% -5.2% -3.6% -3.2% -2.8% -3.4% -3.6% -3.5% -3.0% -2.5% -2.0% -1.4% -0.7% -0.5% -0.9% -1.9% -2.0% -2.02%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.20 0.43 0.14 0.18 0.33 0.12 0.03 0.05 0.14 0.34 0.01 0.00 0.01 0.00 0.20 0.20 0.70 0.56 0.63 0.66 0.662
Earnings Stability 0.05 0.07 0.22 0.30 0.23 0.28 0.66 0.75 0.65 0.64 0.55 0.41 0.11 0.02 0.00 0.04 0.03 0.07 0.17 0.18 0.178
Margin Stability 0.86 0.89 0.84 0.84 0.86 0.85 0.84 0.84 0.86 0.84 0.85 0.85 0.88 0.87 0.90 0.91 0.94 0.93 0.93 0.92 0.923
Rev. Growth Consistency 0.00 0.50 0.00 0.00 0.50 0.00 0.50 0.50 0.00 0.50 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.91 0.96 0.956
Earnings Smoothness 0.00 0.04 0.00 0.43 0.80 0.90 0.896
ROE Trend -0.03 -0.04 -0.06 -0.08 -0.00 -0.02 -0.03 -0.05 -0.04 -0.02 0.03 0.05 0.03 0.05 0.06 0.06 0.08 0.06 0.03 0.02 0.021
Gross Margin Trend -0.13 -0.05 -0.17 -0.15 0.01 -0.13 -0.02 -0.03 -0.05 -0.03 0.03 0.03 -0.01 0.04 -0.02 -0.01 -0.00 -0.01 -0.04 -0.05 -0.049
FCF Margin Trend 0.07 -0.11 0.34 0.29 -0.07 0.22 -0.14 -0.11 -0.08 -0.32 -0.42 -0.43 -0.27 -0.15 -0.03 0.01 0.01 0.05 0.06 0.06 0.060
Sustainable Growth Rate -6.8% -9.0% -7.8% -7.7% -6.2% -5.5% -5.1% -3.7% -4.0% -4.8% -4.9% -4.95%
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -13.25 -6.72 -3.15 -3.31 7.94 -20.35 -4.07 -2.51 -2.55 -3.28 21.85 5.76 5.64 3.18 2.45 2.40 1.86 1.95 2.24 2.35 2.348
FCF/OCF 0.93 0.93 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.72 0.73 0.72 0.73 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 2.348
OCF/EBITDA snapshot only 0.837
CapEx/Revenue 5.3% 4.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 14.2% 12.5% 12.4% 12.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.06 -0.07 -0.08 -0.08 -0.05 -0.06 -0.07 -0.08 -0.07 -0.06 -0.05 -0.04 -0.04 -0.04 -0.03 -0.04 -0.03 -0.03 -0.04 -0.04 -0.039
Sloan Accruals snapshot only -0.231
Cash Flow Adequacy snapshot only 1.248
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 9.3% 11.2% 11.9% 10.6% 11.2% 11.9% 12.3% 13.0% 12.3% 10.2% 9.6% 9.1% 8.6% 6.9% 7.2% 7.1% 6.6% 6.4% 6.0% 6.0% 5.79%
Dividend/Share $1.17 $1.16 $1.16 $1.16 $1.18 $1.20 $1.20 $1.20 $1.19 $1.20 $1.19 $1.19 $1.19 $1.18 $1.17 $1.17 $1.18 $1.17 $1.15 $1.15 $1.20
Payout Ratio 6.3% 20.2% 5.6% 5.3% 2.9% 2.2% 2.0% 1.6% 1.6% 1.9% 1.9% 1.88%
FCF Payout Ratio 80.1% 79.2% 73.8% 76.6% 79.5% 79.9% 87.8% 86.4% 88.1% 1.3% 1.3% 1.4% 1.3% 90.1% 90.2% 83.5% 83.8% 83.7% 83.0% 80.1% 80.11%
Total Payout Ratio 6.4% 20.3% 5.7% 5.4% 2.9% 2.2% 2.0% 1.6% 1.7% 1.9% 1.9% 1.93%
Div. Increase Streak 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number -0.14 -0.04 0.06 0.19 0.20 0.20 0.18 0.16 0.14 0.10 0.10 0.09 0.09 0.07 0.08 0.09 0.09 0.09 0.09 0.10 0.101
Buyback Yield 0.0% 0.0% 0.0% 0.1% 0.2% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.17%
Net Buyback Yield -9.2% -10.1% -7.8% -3.2% 0.1% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% -0.8% -0.8% -0.7% -1.4% -4.2% -4.8% -4.6% -4.57%
Total Shareholder Return 0.0% 1.1% 4.1% 7.4% 11.4% 12.1% 12.5% 13.1% 12.4% 10.3% 9.7% 9.2% 8.6% 6.1% 6.4% 6.3% 5.2% 2.2% 1.3% 1.4% 1.40%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.02 1.01 1.02 1.01 0.97 1.11 1.02 1.01 1.01 1.02 0.87 0.97 0.97 0.99 0.99 0.99 0.99 0.99 0.99 1.00 1.001
Interest Burden (EBT/EBIT) -0.25 -0.22 -3.38 -2.70 0.22 -0.36 -0.54 -0.99 -0.98 -0.87 0.09 0.30 0.32 0.46 0.51 0.54 0.60 0.60 0.58 0.65 0.646
EBIT Margin 0.22 0.40 0.08 0.10 0.36 0.10 0.27 0.24 0.23 0.18 0.26 0.26 0.25 0.31 0.36 0.37 0.41 0.40 0.35 0.30 0.297
Asset Turnover 0.07 0.10 0.06 0.07 0.10 0.07 0.09 0.09 0.09 0.10 0.12 0.12 0.12 0.12 0.13 0.13 0.14 0.14 0.14 0.15 0.151
Equity Multiplier 1.75 1.75 1.76 1.76 1.76 1.76 1.82 1.82 1.82 1.82 1.90 1.90 1.90 1.90 1.93 1.93 1.93 1.93 1.94 1.94 1.941
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.12 $-0.23 $-0.50 $-0.46 $0.19 $-0.07 $-0.34 $-0.55 $-0.53 $-0.38 $0.06 $0.21 $0.22 $0.41 $0.53 $0.59 $0.76 $0.72 $0.62 $0.61 $0.61
Book Value/Share $15.76 $15.35 $14.85 $14.59 $14.59 $14.63 $13.23 $13.22 $13.16 $13.22 $12.02 $12.01 $11.99 $11.82 $11.44 $11.41 $11.38 $11.26 $11.16 $11.02 $11.06
Tangible Book/Share $15.38 $14.98 $14.62 $14.36 $14.35 $14.40 $13.06 $13.05 $12.99 $13.04 $11.89 $11.88 $11.86 $11.69 $11.32 $11.29 $11.26 $11.14 $10.91 $10.77 $10.77
Revenue/Share $2.05 $2.64 $1.71 $1.72 $2.46 $1.80 $2.30 $2.31 $2.33 $2.45 $2.77 $2.80 $2.86 $2.89 $2.93 $3.00 $3.04 $3.06 $3.06 $3.18 $3.22
FCF/Share $1.46 $1.46 $1.57 $1.52 $1.48 $1.50 $1.37 $1.39 $1.35 $0.90 $0.94 $0.88 $0.92 $1.30 $1.30 $1.41 $1.41 $1.40 $1.38 $1.43 $1.45
OCF/Share $1.57 $1.57 $1.57 $1.52 $1.48 $1.50 $1.37 $1.39 $1.35 $1.25 $1.29 $1.22 $1.26 $1.30 $1.30 $1.41 $1.41 $1.40 $1.38 $1.43 $1.45
Cash/Share $0.30 $0.30 $0.49 $0.48 $0.48 $0.48 $0.21 $0.21 $0.21 $0.21 $0.18 $0.18 $0.18 $0.17 $0.25 $0.25 $0.25 $0.25 $0.28 $0.28 $0.49
EBITDA/Share $1.27 $1.86 $0.99 $1.00 $1.72 $1.03 $1.40 $1.37 $1.34 $1.23 $1.50 $1.48 $1.45 $1.62 $1.75 $1.80 $1.97 $1.95 $1.81 $1.71 $1.71
Debt/Share $11.24 $10.94 $10.74 $10.56 $10.55 $10.58 $11.04 $11.03 $10.98 $11.02 $10.49 $10.48 $10.47 $10.32 $10.20 $10.17 $10.15 $10.04 $10.09 $9.96 $9.96
Net Debt/Share $10.93 $10.65 $10.25 $10.07 $10.07 $10.10 $10.82 $10.81 $10.76 $10.81 $10.31 $10.31 $10.29 $10.15 $9.95 $9.92 $9.90 $9.79 $9.81 $9.68 $9.68
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.652
Altman Z-Prime snapshot only -0.246
Piotroski F-Score 2 4 2 3 5 3 4 4 2 4 7 6 6 6 6 6 6 6 6 6 6
Beneish M-Score -1.91 -2.81 -3.35 -2.75 -2.75 -2.71 -2.53 -2.78 -2.82 -2.75 -2.58 -2.66 -2.61 -2.60 -2.70 -2.68 -2.680
Ohlson O-Score snapshot only -7.063
Net-Net WC snapshot only $-9.72
EVA snapshot only $-297440737.01
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B+
Credit Score 28.00 36.26 30.73 32.16 39.57 32.60 27.29 26.81 24.80 22.19 26.26 27.34 25.92 29.52 38.19 38.67 37.65 39.87 31.14 33.25 33.247
Credit Grade snapshot only 14
Credit Trend snapshot only -5.427
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 38
Sector Credit Rank snapshot only 34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms